A mandibular advancement device reduces sleep disordered breathing in patients with congestive heart failure
(2004) In Swedish Dental Journal 28(4). p.155-163- Abstract
- Sleep disordered breathing (SDB) including obstructive and central sleep apnoea/ hypopnoea as well as periodic breathing (PB) is common and is believed to increase risk for mortality in patients with congestive heart failure (CHF). Mandibular advancement device (MAD) has widely been recommended for treatment of obstructive sleep apnoea but the method has never been investigated for treatment of SDB in the patients with CHF. The aim with the present study was to examine the effect of MAD intervention on SDB in patients with CHF. The study included 17 male patients, aged 68.4 +/- 5.7 (mean +/- SD) with stable, mild to moderate CHF due to left ventricular systolic dysfunction and with SDB, expressed as apnoea/hypopnoea index (AHI) >= 10.... (More)
- Sleep disordered breathing (SDB) including obstructive and central sleep apnoea/ hypopnoea as well as periodic breathing (PB) is common and is believed to increase risk for mortality in patients with congestive heart failure (CHF). Mandibular advancement device (MAD) has widely been recommended for treatment of obstructive sleep apnoea but the method has never been investigated for treatment of SDB in the patients with CHF. The aim with the present study was to examine the effect of MAD intervention on SDB in patients with CHF. The study included 17 male patients, aged 68.4 +/- 5.7 (mean +/- SD) with stable, mild to moderate CHF due to left ventricular systolic dysfunction and with SDB, expressed as apnoea/hypopnoea index (AHI) >= 10. The SDB was examined during a single night using an unattended, portable polysomnographic device in the patients home, prior to and following intervention with a individually adjusted MAD. The SDB was evaluated by calculating AHI, PB expressed as the percentage of the total registration time, oxygen desaturation index (ODI) and snoring time. The AHI was reduced by MAD intervention from 25.1 +/- 9.4 to 14.7 +/- 9.7 (P = 0.003). ODI reduced fro M 21.1 +/- 9.0 to 10.5 +/- 7.8 (P = 0.007) and snoring time decreased from 53 +/- 111 to 18 47 seconds (P = 0.02). PB was reduced from 55.7 +/- 25.6 to 40.4 +/- 26.4 per cent without statistical significance. In conclusion, the MAD intervention may be a feasible method for reducing SDB in patients with stable, mild to moderate CHF and left ventricular systolic dysfunction. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/895350
- author
- Eskafi, M ; Cline, Charles LU ; Israelsson, Bo LU and Nilner, M
- organization
- publishing date
- 2004
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- oxygen desaturation index, periodic breathing, advancement device, mandibular, congestive heart failure, sleep disordered breathing
- in
- Swedish Dental Journal
- volume
- 28
- issue
- 4
- pages
- 155 - 163
- publisher
- Sveriges Tandläkarförbund
- external identifiers
-
- pmid:15779492
- wos:000229423700001
- scopus:15044352364
- ISSN
- 0347-9994
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Cardiology (013242100), Emergency medicine/Medicine/Surgery (013240200)
- id
- 9297440a-b4ee-4fb5-ba92-5e839ca52552 (old id 895350)
- date added to LUP
- 2016-04-01 16:42:33
- date last changed
- 2022-01-28 21:34:04
@article{9297440a-b4ee-4fb5-ba92-5e839ca52552,
abstract = {{Sleep disordered breathing (SDB) including obstructive and central sleep apnoea/ hypopnoea as well as periodic breathing (PB) is common and is believed to increase risk for mortality in patients with congestive heart failure (CHF). Mandibular advancement device (MAD) has widely been recommended for treatment of obstructive sleep apnoea but the method has never been investigated for treatment of SDB in the patients with CHF. The aim with the present study was to examine the effect of MAD intervention on SDB in patients with CHF. The study included 17 male patients, aged 68.4 +/- 5.7 (mean +/- SD) with stable, mild to moderate CHF due to left ventricular systolic dysfunction and with SDB, expressed as apnoea/hypopnoea index (AHI) >= 10. The SDB was examined during a single night using an unattended, portable polysomnographic device in the patients home, prior to and following intervention with a individually adjusted MAD. The SDB was evaluated by calculating AHI, PB expressed as the percentage of the total registration time, oxygen desaturation index (ODI) and snoring time. The AHI was reduced by MAD intervention from 25.1 +/- 9.4 to 14.7 +/- 9.7 (P = 0.003). ODI reduced fro M 21.1 +/- 9.0 to 10.5 +/- 7.8 (P = 0.007) and snoring time decreased from 53 +/- 111 to 18 47 seconds (P = 0.02). PB was reduced from 55.7 +/- 25.6 to 40.4 +/- 26.4 per cent without statistical significance. In conclusion, the MAD intervention may be a feasible method for reducing SDB in patients with stable, mild to moderate CHF and left ventricular systolic dysfunction.}},
author = {{Eskafi, M and Cline, Charles and Israelsson, Bo and Nilner, M}},
issn = {{0347-9994}},
keywords = {{oxygen desaturation index; periodic breathing; advancement device; mandibular; congestive heart failure; sleep disordered breathing}},
language = {{eng}},
number = {{4}},
pages = {{155--163}},
publisher = {{Sveriges Tandläkarförbund}},
series = {{Swedish Dental Journal}},
title = {{A mandibular advancement device reduces sleep disordered breathing in patients with congestive heart failure}},
volume = {{28}},
year = {{2004}},
}